908 Devices (MASS) EBT (QoQ) (2020 - 2026)
908 Devices (MASS) EBT (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | 908 Devices | 389.35 Mn | 287.82 Mn | 8.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.43% |
| Mar 31, 2026 | -453.21% |
| Dec 31, 2025 | 128.30% |
| Sep 30, 2025 | -15.92% |
| Jun 30, 2025 | 1.72% |
| Mar 31, 2025 | 18.49% |
| Dec 31, 2024 | 32.24% |
| Sep 30, 2024 | -212.27% |
| Jun 30, 2024 | 31.07% |
| Mar 31, 2024 | -47.85% |
| Dec 31, 2023 | -3.50% |
| Sep 30, 2023 | 23.75% |
| Jun 30, 2023 | 24.86% |
| Mar 31, 2023 | -28.00% |
| Dec 31, 2022 | -56.43% |
| Sep 30, 2022 | 22.72% |
| Jun 30, 2022 | 24.16% |
| Mar 31, 2022 | -116.31% |
| Dec 31, 2021 | 23.54% |
| Sep 30, 2021 | 23.54% |